2009
DOI: 10.1016/j.yexmp.2008.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Expression and tissue localization of β-catenin, α-actinin and chondroitin sulfate proteoglycan 6 is modulated during rat and human left ventricular hypertrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 43 publications
0
5
0
Order By: Relevance
“…One of these factors, Mkl1, itself regulates expression of cytoskeletal genes during megakaryopoiesis. Three of the factors, α-actinin, Hic-5, and Mkl1, have been implicated in cardiomyocyte hypertrophy (Kuwahara et al, 2010; Ridinger et al, 2009; Yund et al, 2009). Two of the factors, α-actinin and filamin A, function in actin cross-linkage, leading to F-actin stabilization (Mukhina et al, 2007; Nakamura et al, 2011), and our data suggest that α-actinin may regulate filamin A levels in megakaryocytes (Figure 6A).…”
Section: Discussionmentioning
confidence: 99%
“…One of these factors, Mkl1, itself regulates expression of cytoskeletal genes during megakaryopoiesis. Three of the factors, α-actinin, Hic-5, and Mkl1, have been implicated in cardiomyocyte hypertrophy (Kuwahara et al, 2010; Ridinger et al, 2009; Yund et al, 2009). Two of the factors, α-actinin and filamin A, function in actin cross-linkage, leading to F-actin stabilization (Mukhina et al, 2007; Nakamura et al, 2011), and our data suggest that α-actinin may regulate filamin A levels in megakaryocytes (Figure 6A).…”
Section: Discussionmentioning
confidence: 99%
“…Although the actions of Klf7 and Sec62 in the heart are currently unknown, Klf7 has been reported as a susceptibility gene in type 2 diabetes (Kanazawa et al, 2005), and the overexpression of Klf7 in human adipocytes reportedly decreases adiponectin and leptin levels and increases IL-6 ( Kawamura et al, 2006). Moreover, a previous study demonstrated that the mRNA expression of Smc3 was increased in the rat model and patients with left ventricular hypertrophy (Ridinger et al, 2009). Finally, tissue inhibitor of metalloproteinase (TIMP)-3, an endogenous inhibitor of matrix metalloproteinases, may be involved in heart failure (Li et al, 1998).…”
Section: Discussionmentioning
confidence: 99%
“…The capacity of SPARC to influence TGF-β1 signal transduction and myofibroblast differentiation will be discussed further below. In human heart disease, SPARC expression was found to be elevated in tissue sections from ventricles of individuals with left ventricular hypertrophy in one study [23]. More extensive characterization of SPARC in human heart disease will be an important and primary focus of future studies.…”
Section: Sparcmentioning
confidence: 99%